Company Lookup
عربي
Download Demo
 

Market News

This Month News

This Month News

send to a friend by email

BPC posts net income of $5.48 million in 2013

2014-02-17

According to Birzeit Pharmaceuticals Company ( BPC) data for year-end preliminary financial statements for year 2013, net profit after taxes reached 5,480,204 USD, compared with a net profit after taxes of 4,785,914 USD in the audited data for 2012, a net increase of 14.5%. Total assets of the company reached 64,753,100 USD as of December 31st, 2013, compared to total assets of 59,958,678 USD as of December 31st, 2012, a net increase of 8.0%. Total liabilities of the company reached 12,828,330 USD as of December 31st, 2013, compared to total liabilities of 11,736,829 USD as of December 31st, 2012, a net increase of 9.3%. Net ownership equity of the company reached 51,924,770 USD (including 199,413 USD in Non-controlling interest) as of December 31st, 2013, compared with a net ownership equity of 48,221,849 USD (including 336,020 USD in Non-controlling interest) as of December 31st, 2012, a net increase of 7.7%. Furthermore, paid-in capital increased from 18,490,177 USD  on December 31st, 2012 to 18,502,825 USD  by December 31st, 2013, an increase of 0.01%.

 


 

2021-10-27
PID posts net income of JD0.65 million in 9M 2021

2021-10-27
NAPCO posts net income of JD0.34 million in 9M 2021

2021-10-26
RSR posts net income of JD0.31 million in 9M 2021

2021-10-26
APC records net income of JD0.82 million in 9M 2021

2021-10-24
ARAB posts net income of JD0.02 million in 9M 2021

2021-10-21
Al-Quds Index in a narrow range amid an increase in 9M financial data disclosures anticipation

2021-10-17
PHARMACARE recommends distributing 10% cash dividends for the year 2020

2021-10-14
A transaction on the stocks of TRSUT raises the trading value in the PEX

2021-10-07
Al-Quds Index rebounds upwards in the first week of October

 

 

 
Sahem Trading & Investments Company - PEX Member and licensed by PCMA
© All Rights Reserved 2013